ARTICLE | Company News
Epimmune other research news
March 12, 2001 8:00 AM UTC
EPMN said it has developed a process for creating antigenic peptides that are related to the non-antigenic tumor epitopes HLA-A2.1. The analogs induced CTL activity. Data were presented at the Colloqu...